Have a feature idea you'd love to see implemented?
Let us know!
KOD Kodiak Sciences Inc
Price (delayed)
$5.9
Market cap
$310.48M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.65
Enterprise value
$179.87M
Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new
Highlights
The EPS has grown by 30% YoY and by 2.9% from the previous quarter
Kodiak Sciences's net income has increased by 29% YoY and by 3.1% QoQ
Kodiak Sciences's quick ratio has soared by 71% YoY but it has decreased by 20% from the previous quarter
The equity has declined by 39% year-on-year and by 14% since the previous quarter
Key stats
What are the main financial stats of KOD
Market
Valuations
Earnings
Shares outstanding
52.62M
Market cap
$310.48M
Enterprise value
$179.87M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.67
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$191.62M
EBITDA
-$164.93M
Free cash flow
-$147.25M
Per share
Balance sheet
Liquidity
EPS
-$3.65
Free cash flow per share
-$2.8
Book value per share
$3.52
Revenue per share
$0
TBVPS
$7.08
Total assets
$372.67M
Total liabilities
$187.3M
Debt
$73.44M
Equity
$185.37M
Working capital
$178.43M
Debt to equity
0.4
Current ratio
8.42
Quick ratio
8.48
Net debt/EBITDA
0.79
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-45.4%
Return on equity
-84.5%
Return on invested capital
-84%
Return on capital employed
-55%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KOD stock price
How has the Kodiak Sciences stock price performed over time
Intraday
1.9%
1 week
11.32%
1 month
60.76%
1 year
162.22%
YTD
94.08%
QTD
126.05%
Financial performance
How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$204.04M
Net income
-$191.62M
Gross margin
N/A
Net margin
N/A
Kodiak Sciences's net income has increased by 29% YoY and by 3.1% QoQ
The operating income has grown by 29% YoY and by 3.7% from the previous quarter
Growth
What is Kodiak Sciences's growth rate over time
Valuation
What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
1.67
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 30% YoY and by 2.9% from the previous quarter
The stock's P/B is 109% above its last 4 quarters average of 0.8 but 55% below its 5-year quarterly average of 3.7
The equity has declined by 39% year-on-year and by 14% since the previous quarter
Efficiency
How efficient is Kodiak Sciences business performance
KOD's return on equity is down by 14% year-on-year and by 9% since the previous quarter
The ROA has contracted by 7% from the previous quarter and by 2.3% YoY
KOD's ROIC is up by 4.1% since the previous quarter and by 2.2% year-on-year
Dividends
What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KOD.
Financial health
How did Kodiak Sciences financials performed over time
The total assets is 99% greater than the total liabilities
Kodiak Sciences's quick ratio has soared by 71% YoY but it has decreased by 20% from the previous quarter
KOD's current ratio has surged by 70% year-on-year but it is down by 20% since the previous quarter
KOD's debt is 60% lower than its equity
KOD's debt to equity is up by 43% YoY and by 14% from the previous quarter
The equity has declined by 39% year-on-year and by 14% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.